Jefferies Maintains “Buy” Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning

MSN
2025.11.17 03:32
portai
I'm PortAI, I can summarize articles.

Jefferies analyst Roger Song maintains a "Buy" rating for Wave Life Sciences (NASDAQ:WVE), highlighting its improving competitive positioning and significant upside potential. The company is considered one of the best small-cap biotech stocks to buy, especially after Korro Bio's KRRO-110 failed to produce protective levels, enhancing Wave Life Sciences' market position.

Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer